PSMB10
Basic information
Region (hg38): 16:67934505-67936864
Previous symbols: [ "MECL1" ]
Links
Phenotypes
GenCC
Source:
- proteasome-associated autoinflammatory syndrome 5 (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Immunodeficiency 121 with autoinflammation; Proteasome-associated autoinflammatory syndrome 5 | AD/AR | Allergy/Immunology/Infectious | Immunodeficiency 121 with autoinflammation involves severe immunodeficiency, and awareness may allow early and aggressive treatment of infections as well as preventative measures; HSCT has been described, but complications have been reported in multiple individuals; Proteasome-associated autoinflammatory syndrome 5 involves autoinflammatory manifestations, and medical management (eg, with steroids and methotrexate) has been described as beneficial | Allergy/Immunology/Infectious; Dermatologic | 31783057; 38503300 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PSMB10 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 10 | 13 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 11 | 5 | 0 |
Variants in PSMB10
This is a list of pathogenic ClinVar variants found in the PSMB10 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-67934646-C-T | Proteasome-associated autoinflammatory syndrome 5 • not specified | Uncertain significance (Aug 08, 2023) | ||
16-67934663-C-A | not specified | Uncertain significance (May 21, 2024) | ||
16-67934664-G-A | not specified | Uncertain significance (Mar 31, 2023) | ||
16-67934671-C-T | not specified | Likely benign (Oct 13, 2023) | ||
16-67934796-C-G | Proteasome-associated autoinflammatory syndrome 5 | Pathogenic (Jun 11, 2024) | ||
16-67934804-C-T | not specified | Uncertain significance (Dec 07, 2023) | ||
16-67934847-A-G | Likely benign (Sep 01, 2022) | |||
16-67934864-A-T | not specified | Uncertain significance (Apr 17, 2023) | ||
16-67934878-C-T | Proteasome-associated autoinflammatory syndrome 5 | Uncertain significance (Jun 01, 2022) | ||
16-67934906-C-G | Immunodeficiency 121 with autoinflammation | Pathogenic (Jun 11, 2024) | ||
16-67934906-C-T | Immunodeficiency 121 with autoinflammation | Pathogenic (Jun 11, 2024) | ||
16-67935478-C-T | Proteasome-associated autoinflammatory syndrome 5 | Pathogenic (Jun 11, 2024) | ||
16-67935657-C-T | not specified | Uncertain significance (Feb 17, 2022) | ||
16-67935680-C-T | not specified | Uncertain significance (Dec 28, 2022) | ||
16-67935979-G-A | not specified | Likely benign (Nov 22, 2023) | ||
16-67935985-T-C | not specified | Likely benign (May 23, 2023) | ||
16-67936095-C-T | not specified | Uncertain significance (Mar 01, 2024) | ||
16-67936098-C-CA | Proteasome-associated autoinflammatory syndrome 5 | Pathogenic (Jun 11, 2024) | ||
16-67936239-ATCT-A | PSMB10-related disorder | Uncertain significance (Mar 14, 2023) | ||
16-67936291-C-G | Immunodeficiency 121 with autoinflammation | Pathogenic (Jun 11, 2024) | ||
16-67936309-C-G | not specified | Uncertain significance (Mar 31, 2022) | ||
16-67936697-T-G | Likely benign (Jan 01, 2023) | |||
16-67936705-C-A | not specified | Uncertain significance (Jan 30, 2024) | ||
16-67936707-CGAA-C | Proteasome-associated autoinflammatory syndrome 5 | Pathogenic (Jun 11, 2024) | ||
16-67936709-A-G | Proteasome-associated autoinflammatory syndrome 5 | Pathogenic (Jun 11, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PSMB10 | protein_coding | protein_coding | ENST00000358514 | 8 | 2586 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000177 | 0.445 | 125704 | 0 | 44 | 125748 | 0.000175 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.694 | 139 | 164 | 0.848 | 0.00000795 | 1705 |
Missense in Polyphen | 24 | 47.872 | 0.50133 | 494 | ||
Synonymous | 0.0879 | 74 | 75.0 | 0.987 | 0.00000395 | 610 |
Loss of Function | 0.630 | 10 | 12.4 | 0.807 | 5.30e-7 | 144 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00119 | 0.00116 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.0000927 | 0.0000924 |
European (Non-Finnish) | 0.000141 | 0.000141 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000983 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: The proteasome is a multicatalytic proteinase complex which is characterized by its ability to cleave peptides with Arg, Phe, Tyr, Leu, and Glu adjacent to the leaving group at neutral or slightly basic pH. The proteasome has an ATP-dependent proteolytic activity. This subunit is involved in antigen processing to generate class I binding peptides.;
- Pathway
- Proteasome - Homo sapiens (human);Proteasome Degradation;TLR NFkB;B cell receptor signaling;Post-translational protein modification;Metabolism of proteins;DroToll-like;Notch;Hedgehog;IL-1 NFkB;IL-1 p38;IL-1 JNK;TGF-beta super family signaling pathway canonical;TLR p38;UCH proteinases;Neddylation;Ub-specific processing proteases;JAK STAT pathway and regulation;Deubiquitination;TLR JNK;TNF;Wnt Canonical;Wnt Mammals;CD4 T cell receptor signaling-NFkB cascade;CD4 T cell receptor signaling
(Consensus)
Recessive Scores
- pRec
- 0.191
Intolerance Scores
- loftool
- 0.693
- rvis_EVS
- -0.41
- rvis_percentile_EVS
- 26.23
Haploinsufficiency Scores
- pHI
- 0.678
- hipred
- Y
- hipred_score
- 0.595
- ghis
- 0.585
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.525
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Psmb10
- Phenotype
- homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); immune system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype;
Gene ontology
- Biological process
- cell morphogenesis;humoral immune response;proteasomal protein catabolic process;proteasomal ubiquitin-independent protein catabolic process;viral process;protein deubiquitination;T cell proliferation;proteasome-mediated ubiquitin-dependent protein catabolic process;post-translational protein modification
- Cellular component
- proteasome complex;nucleus;nucleoplasm;cytoplasm;cytosol;proteasome core complex;proteasome core complex, beta-subunit complex;spermatoproteasome complex
- Molecular function
- endopeptidase activity;threonine-type endopeptidase activity;protein binding